ARYA Sciences Acquisition Corp. IV (ARYD)
| Market Cap | 167.10M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 16.71M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
ARYA Sciences Acquisition Corp IV (the “Company”), a special purpose acquisition company formed for the...
ARYA Sciences Acquisition IV, the fourth healthcare-focused blank check company formed by Perceptive Advisors, filed on Wednesday with the SEC to raise up to $130 million in an initial public ...
ARYA Sciences Acquisition Corp. IV has filed to go public with an IPO on the NASDAQ.
About ARYD
ARYA Sciences Acquisition IV is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, we will target North American or European companies in... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Feb 26, 2021 |
| CEO Adam Stone | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol ARYD |